Sam Harirforoosh

Professor

Pharmacy, School of Pharmacy

Expertise: Pharmaceutics; Pharmacokinetic/Pharmacodynamic Modeling; Safety Pharmacology; Pharmacogenomics

Office Location: RK-94 297R

Education:: Tehran University of Medical Sciences, Doctor of Pharmacy
University of Alberta, Ph.D.

Biography

Dr. Sam Harirforoosh joined Chapman University School of Pharmacy (CUSP) as an Instructional Professor of Biomedical and Pharmaceutical Sciences in 2022. He earned his Pharm.D. from Tehran University of Medical Sciences in 1991 and his Ph.D. in Pharmaceutical Sciences (Pharmacokinetics) from the University of Alberta in 2005. His dissertation focused on the pharmacokinetics and renal effects of nonsteroidal anti-inflammatory drugs. He also worked as a research assistant/post-doctoral fellow at the University of Alberta's Department of Medicine from the summer of 2005 to the spring of 2006. Additionally, he is a registered pharmacist in the province of Alberta, Canada.

Before joining CUSP, Dr. Harirforoosh was a tenured professor in the Department of Pharmaceutical Sciences at East Tennessee State University's Gatton College of Pharmacy. He coordinated and taught courses in pharmacokinetics, pharmacogenomics, and drug metabolism. He received the Gatton College of Pharmacy Outstanding Teacher Award (presented by the class of 2017) for teaching Pharmacokinetics and Pharmacogenomics. In 2023, he received CUSP's Most Outstanding Teacher award for the 2022-2023 academic year, presented by the Class of 2025.

Dr. Harirforoosh has authored or co-authored 45+ peer-reviewed articles and 80+ abstracts. He has served on the editorial boards of the journals Clinical Pharmacokinetics and the European Journal of Drug Metabolism and Pharmacokinetics. He has delivered numerous lectures at local, national, and international conferences, received two research awards from the Gatton College of Pharmacy for his research achievements, and served as an abstract reviewer, grant reviewer, and peer reviewer for various scientific journals. He has also been a research advisor for 45+ Ph.D., Pharm.D., M.PH., and undergraduate students.

Dr. Harirforoosh's research interests include applying artificial intelligence tools to pharmacokinetic outcomes, pharmacokinetic/pharmacodynamic modeling, pharmacogenomics, cardiovascular and renal adverse effects of drugs, and nanoparticle formulation of drugs.

Recent Creative, Scholarly Work and Publications: Fankhouser, R. W., Murrell, D. E., Anane, Y. Y., Hurley, D. L., Mamudu, H. M., & Harirforoosh, S. (2022). Type 2 diabetes: an exploratory genetic association analysis of selected metabolizing enzymes and transporters and effects on cardiovascular and renal biomarkers. Drug Metab Pers Ther, 37(4), 375-382.; Omoike, O. E., Paul, T. K., Ridner, S. L., Awasthi, M., Harirforoosh, S., & Mamudu, H. M. (2020). Association between smoking status and homocysteine levels and possible effect modification by cholesterol and oestradiol. Biomarkers, 25(2), 126-130.; Thigpen, J. C., Odle, B. L., & Harirforoosh, S. (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. Eur J Drug Metab Pharmacokinet, 44(5), 591-609.; Pond, B. B., Brown, S. D., Stewart, D. W., Roane, D. S., & Harirforoosh, S. (2019). Faculty Applicants' Attempt to Inflate CVs Using Predatory Journals. Am J Pharm Educ, 83(1), 7210.; Murrell, D. E., Cluck, D. B., Moorman, J. P., Brown, S. D., Wang, K. S., Duffourc, M. M., & Harirforoosh, S. (2019). HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study. Clin Drug Investig, 39(3), 285-299.; Salwan, A. J., Hagemeier, N. E., & Harirforoosh, S. (2018). Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Clin Drug Investig, 38(7), 573-577.; Chen, Y., Xu, C., Harirforoosh, S., Luo, X., & Wang, K. S. (2018). Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol. J Psychiatr Res, 96, 65-72.; Mamudu, H. M., Subedi, P., Paul, T., Alamin, A. E., Alamian, A., Wang, L., Stewart, D., Jones, A., Harirforoosh, S., Blackwell, G., & Budoff, M. (2018). The associated risk factors for coronary artery calcium in asymptomatic individuals with and without diabetes in rural Central Appalachia. J Diabetes Complications, 32(10), 900-905.

Sam Harirforoosh

Biography

Recent Creative, Scholarly Work and Publications

Faculty Directories by School or College